Research on HPV prevalence in young gay and bisexual men
A Cross-sectional Study to Evaluate the Prevalence of HPV in Gay and Bisexual Men Aged 16-20 Years in Australia
Monash University · NCT05587725
This study looks at how common HPV is in young gay and bisexual men aged 16-20 in Australia to better understand their risk for anal cancer.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 16 Years to 20 Years |
| Sex | Male |
| Sponsor | Monash University (other) |
| Locations | 1 site (Melbourne, Victoria) |
| Trial ID | NCT05587725 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the prevalence of anal, genital, and oral HPV among 200 young gay and bisexual men aged 16-20 years in Australia, who were eligible for the school-based 9-valent HPV vaccination program. Participants will complete a questionnaire and provide samples for HPV testing, with no follow-up visits required. The study focuses on a population that is particularly at risk for anal cancer, especially among those living with HIV.
Who should consider this trial
Good fit: Ideal candidates for this study are young men aged 16 to 20 who identify as gay or bisexual and have resided in Australia since 2018.
Not a fit: Patients who do not identify as same-sex attracted or who are unable to complete study requirements in English may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into HPV prevalence and inform public health strategies for vaccination and prevention in at-risk populations.
How similar studies have performed: Other studies have shown success in assessing HPV prevalence and the impact of vaccination programs, making this approach both relevant and necessary.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men aged 16 to 20 (i.e. men aged 16-18 years in 2023; men aged 16-19 years in 2024; and men aged 16-20 years in 2025 will be recruited. This is to ensure these men would have been eligible for the 9-valent school-based HPV program) * Same-sex attracted * Residing in Australia since 2018 Exclusion Criteria: * Unable to complete all study requirements in English
Where this trial is running
Melbourne, Victoria
- Melbourne Sexual Health Centre — Melbourne, Victoria, Australia (RECRUITING)
Study contacts
- Study coordinator: Eric Chow, PhD
- Email: eric.chow@monash.edu
- Phone: +61393416233
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Human Papillomavirus Infection, HPV, HPV Infection, Anal Cancer, Cancer, Men, HPV 16 Infection, Vaccination